Volume 26, Number 11—November 2020
Research
Analysis of SARS-CoV-2 Transmission in Different Settings, Brunei
Liling Chaw
, Wee Chian Koh, Sirajul Adli Jamaludin, Lin Naing, Mohammad Fathi Alikhan, and Justin Wong
, Wee Chian Koh, Sirajul Adli Jamaludin, Lin Naing, Mohammad Fathi Alikhan, and Justin Wong
Table 1
Demographic and clinical characteristics of cases in a cluster of coronavirus disease among a Tablighi Jamaat community, Brunei
| Characteristics | Overall, n = 71 | Primary cases, n = 19 | Nonprimary cases, n = 52 | p value |
|---|---|---|---|---|
| Median age, y (IQR) | 33.0 (21–50) | 35.0 (33– 59.5) | 29.0 (20–46) | 0.009 |
| Range |
0.75–68 |
17–64 |
0.75–68 |
|
| Age group, y | ||||
| 0–9 | 4 (5.6) | 0 (0.0) | 4 (5.6) | 0.002 |
| 10–19 | 9 (12.7) | 1 (1.4) | 8 (11.3) | |
| 20–29 | 16 (22.5) | 1 (1.4) | 15 (21.1) | |
| 30–39 | 14 (19.7) | 8 (11.3) | 6 (8.5) | |
| 40–49 | 10 (14.1) | 1 (1.4) | 9 (12.7) | |
| 50–59 | 11 (15.5) | 3 (4.2) | 8 (11.3) | |
| 60–69 |
7 (9.9) |
5 (7.0) |
2 (2.8) |
|
| Sex | ||||
| F | 25 (35.2) | 0 (0.0) | 25 (48.1) | <0.001 |
| M |
46 (64.8) |
19 (100) |
27 (51.9) |
|
| Underlying conditions | ||||
| Obesity | 4 (5.6) | 2 (10.5) | 2 (3.8) | 0.289 |
| Heart disease | 4 (5.6) | 3 (15.8) | 1 (1.9) | 0.056 |
| Respiratory disease | 5 (7.0) | 2 (10.5) | 3 (5.8) | 0.605 |
| Cancer | 1 (1.4) | 1 (5.3) | 0 (0.0) | 0.268 |
| Diabetes mellitus |
5 (7.0) |
3 (15.8) |
2 (3.8) |
0.115 |
| Symptom status | ||||
| Symptomatic | 40 (56.3) | 8 (42.1) | 32 (61.5) | 0.265 |
| Median time from symptom onset to diagnosis, d (range; IQR) | 4.0 (0–15; 2–6) | 3.5 (0–7; 2.75–6) | 4.0 (1–15; 2–6.25) | 0.746 |
| Presymptomatic | 22 (31.0) | 7 (36.8) | 15 (28.8) | |
| Median time from symptom to and NP swab collection, d (range; IQR) | 0 (−7 to −1; –2.5 to 0) | 0 (−1 to 1; 0–1) | 0 (−7 to 1; –3 to 0) | 0.034 |
| Asymptomatic |
9 (12.7) |
4 (21.1) |
5 (9.5) |
|
| Symptoms ever reported | ||||
| Fever | 42 (59.2) | 9 (47.4) | 33 (63.5) | 0.343 |
| Cough | 42 (59.2) | 14 (73.7) | 28 (53.8) | 0.218 |
| Runny nose | 25 (35.2) | 7 (36.8) | 18 (34.6) | 1.000 |
| Sore throat |
42 (59.2) |
9 (47.4) |
33 (63.5) |
0.342 |
| Disease severity | ||||
| Asymptomatic | 9 (12.7) | 4 (21.1) | 5 (9.6) | 0.278 |
| Mild | 52 (73.2) | 12 (63.2) | 40 (76.9) | |
| Moderate | 7 (9.9) | 2 (10.5) | 5 (9.6) | |
| Severe or critical | 3 (4.2) | 1 (5.3) | 2 (3.9) |
*Values are no. (%) except as indicated. IQR, interquartile range; NP, nasopharyngeal.
Page created: August 17, 2020
Page updated: October 17, 2020
Page reviewed: October 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.